| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 09/05/2002 | US20020123652 2-aminotetralines and pharmaceutical compositions for the prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies |
| 09/05/2002 | US20020123632 Substituted anthranilic acids, their use as a medicament or diagnostic, and medicament comprising them, and a pharmaceutical combination preparation containing a sodium/hydrogen exchange (NHE) blocker |
| 09/05/2002 | US20020123614 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 09/05/2002 | US20020123529 Anti-arrhythmia, -ischemic, -proliferative and -diabetic agents; cardiotonic, necrosis; angina pectoris; peripheral and central nervous systems; protecting/preserving organs; inhibition of Na+/H+ exchange; diagnosis hypertonia |
| 09/05/2002 | US20020123525 Protecting a heart against oxidative stress by administering a synergistic composition comprising pyruvate, a compound imparting oxidation resistance and a lipid(s), e.g. fatty acid; heart attack, failure; antiischemic agents; transplants |
| 09/05/2002 | US20020123524 Treatment of vascular events using lipid-modifying compositions |
| 09/05/2002 | US20020123520 3',5'-cyclic nucleotide phosphodiesterases (PDEs); disease related to eosinophils, such as asthma, chronic bronchitis, and chronic obstructuive pulmonary disease |
| 09/05/2002 | US20020123519 Amlodipine fumarate |
| 09/05/2002 | US20020123518 Amide derivative of amlodipine |
| 09/05/2002 | US20020123510 Administering an NR2B subtype selective N-methyl-D-aspartate (NMDA) receptor antagonist with a thrombolytic agent for treating hypoxic or ischemic stroke |
| 09/05/2002 | US20020123505 Stents, catheters, arterio-venous grafts, by-pass grafts and drug delivery ballons with surface coating containing a rapamycin derivative having a tetrazole group |
| 09/05/2002 | US20020123501 Useful for premature aging, rheumatoid arthritis, Alzheimer's disease, uremia, neurotoxicity, atherosclerosis and spoilage of proteins in food |
| 09/05/2002 | US20020123500 CSAIDs.TM block cytokine production; use of a cytokine inhibitor for the treatment of chronic diseases which are caused by inappropriate angiogenesis, such as diabetic retinopathy, tumors, atherosclerosis and arthritis |
| 09/05/2002 | US20020123495 For therapy of vagal dysfunction in the heart, improving cardiac function, therapy of person susceptible to cardiac death |
| 09/05/2002 | US20020123494 For therapy of vagal dysfunction in the heart, improving cardiac function, therapy of person susceptible to cardiac death |
| 09/05/2002 | US20020123493 For therapy and prophylaxis of neuronal damage |
| 09/05/2002 | US20020123492 Beta-amino acid derivatives |
| 09/05/2002 | US20020123488 Pyrazine and triazine derivatives of 1,2,4,5-tetrahydro-Benzo or Thieno [d] azepine |
| 09/05/2002 | US20020123485 For therapy of hypertension, cirrhosis and ascites |
| 09/05/2002 | US20020123484 For therapy of immunologic disorders such as transplant rejection, rheumatoid arthritis. multiple sclerosis, inflammatory bowel disease, lupus, graft vs. host disease |
| 09/05/2002 | US20020123141 Recovering embryonic-like stem cells from a placenta; obtain placenta, drain cord blood, flush placenta with anticoagulant solution, recover cells |
| 09/05/2002 | US20020123120 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 09/05/2002 | US20020123119 Nucleotide sequences coding enzymatic polypeptide for use in screening bactericides and for treatment and prevention of infections |
| 09/05/2002 | US20020123099 Highly expressible genes |
| 09/05/2002 | US20020123093 Compounds and methods for lowering cholesterol levels without inducing hypertrigylceridemia |
| 09/05/2002 | US20020123047 dexB |
| 09/05/2002 | US20020122857 Adding an organic solvent to an aqueous extract of soybeans and purifying precipitate |
| 09/05/2002 | US20020122817 Solid instant-release forms of administration and process for producing the same |
| 09/05/2002 | US20020122814 Nitric oxide associated with and releasable from a polyurea network formed from reaction (a) a polyisocyanate; (b) an amine donor; (c) an isocyanatosilane adduct having a terminal isocyanate group and an alkoxysilane group |
| 09/05/2002 | US20020122793 Heparinase III and uses thereof |
| 09/05/2002 | DE10110325A1 Phenylderivate 2 Phenyl derivatives 2 |
| 09/05/2002 | DE10109867A1 Verwendung von Triazolverbindungen zur Prophylaxe und Therapie neurodegenerativer Erkrankungen, Hirntrauma und zerebraler Ischämie Use of triazole compounds for the prophylaxis and treatment of neurodegenerative diseases, brain trauma and cerebral ischemia |
| 09/05/2002 | DE10109866A1 Triazolverbindungen und deren Verwendung zur Prophylaxe und Therapie neurodegenerativer Erkrankungen, Hirntrauma und zerebraler Ischämie Triazole compounds and their use for the prophylaxis and therapy of neurodegenerative diseases, brain trauma and cerebral ischaemia |
| 09/05/2002 | DE10109861A1 Neuartige seitenkettenhalogenierte Aminodicarbonsäurederivate Novel side-chain halogenated Aminodicarbonsäurederivate |
| 09/05/2002 | DE10109859A1 Neuartige Aminodicarbonsäurederivate Novel Aminodicarbonsäurederivate |
| 09/05/2002 | DE10109858A1 Neuartige halogensubstituierte Aminodicarbonsäurederivate Novel halogen-substituted Aminodicarbonsäurederivate |
| 09/04/2002 | EP1236800A2 Nucleic acids encoding interferon alpha 2, containing single nucleotide polymorphisms and methods of use thereof |
| 09/04/2002 | EP1236735A1 Benzamidine derivatives |
| 09/04/2002 | EP1236725A1 Novel 1,8-naphthyridin-2(1h)-one derivatives |
| 09/04/2002 | EP1236723A1 Sulfamide derivatives useful as beta3 agonists and pharmaceutical uses thereof |
| 09/04/2002 | EP1236719A1 Novel heterocyclic compounds and salts thereof and medicinal use of the same |
| 09/04/2002 | EP1236712A1 Amidinophenylpyruvic acid derivative |
| 09/04/2002 | EP1236711A2 Using allosteric hemoglobin modifiers to decrease oxygen affinity in blood |
| 09/04/2002 | EP1236477A2 A formative agent of protein complex |
| 09/04/2002 | EP1236471A2 Angiostatic steroids |
| 09/04/2002 | EP1236470A2 Angiostatic steroids |
| 09/04/2002 | EP1236469A2 Angiostatic steroids |
| 09/04/2002 | EP1236468A1 Sulfonylaminocarbonyl derivatives for the treatment of nuclear factor-kappa B mediated diseases and disorders |
| 09/04/2002 | EP1235912A2 Tumour-specific vector for gene therapy |
| 09/04/2002 | EP1235907A1 6 human secreted proteins |
| 09/04/2002 | EP1235860A2 G-protein coupled receptors |
| 09/04/2002 | EP1235846A1 Uteroglobin-like polynucleotides, polypeptides, and antibodies |
| 09/04/2002 | EP1235844A1 28 human secreted proteins |
| 09/04/2002 | EP1235843A1 26 human secreted proteins |
| 09/04/2002 | EP1235838A1 23 human secreted proteins |
| 09/04/2002 | EP1235837A1 Kringle domain-containing polynucleotides, polypeptides, and antibodies |
| 09/04/2002 | EP1235831A2 New oxabispidine compounds useful in the treatment of cardiac arrhythmias |
| 09/04/2002 | EP1235825A1 Novel benzoimidazole derivatives useful as antiproliferative agents |
| 09/04/2002 | EP1235824A1 Vitamin d analogues |
| 09/04/2002 | EP1235815A1 Quinazolines and their use for inhibiting cyclin-dependent kinase enzymes |
| 09/04/2002 | EP1235814A1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/p38 KINASE INHIBITORS |
| 09/04/2002 | EP1235812A2 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 09/04/2002 | EP1235810A1 Process of making substituted pyrazoles |
| 09/04/2002 | EP1235809A1 Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and the use thereof as medicaments |
| 09/04/2002 | EP1235807A1 B-amino acid-, aspartic acid- and diaminopropionic-based inhibitors of factor xa |
| 09/04/2002 | EP1235798A1 1,4 substituted piperidinyl nmda/nr2b antagonists |
| 09/04/2002 | EP1235797A1 Aralkyl-1,2-diamines having calcimimetic activity and preparation mode |
| 09/04/2002 | EP1235777A2 Vitamin d analogues |
| 09/04/2002 | EP1235776A1 Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
| 09/04/2002 | EP1235618A2 Bioconjugation in vivo to pulmonary or blood components |
| 09/04/2002 | EP1235592A1 COMBINATION OF COMPOUNDS THAT INHIBIT THE BIOLOGICAL EFFECTS OF TNF-$g(a) AND CD95L IN A MEDICAMENT |
| 09/04/2002 | EP1235586A1 Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions |
| 09/04/2002 | EP1235574A2 Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof |
| 09/04/2002 | EP1235572A2 Method to treat pain utilizing benzimidazole nmda/nr2b antagonists |
| 09/04/2002 | EP1235567A2 Inhibitors of collagen-induced platelet aggregation |
| 09/04/2002 | EP1235565A1 Use of 5ht 3 agonists for relaxing the fundus |
| 09/04/2002 | EP1235562A1 Chronotherapeutic diltiazem formulations and the administration thereof |
| 09/04/2002 | EP1150974B1 Heterocyclic derivatives as inhibitors of factor xa |
| 09/04/2002 | EP1054886B1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors, in particular as urokinase inhibitors |
| 09/04/2002 | EP1037888B1 (e)-3-[1-n-butyl- 5-[2-(2-carboxyphenyl)methoxy- 4-chlorophenyl]-1h- pyrazol-4-yl]-2- [(5- methoxy-2,3- dihydrobenzofuran-6-yl)methyl]- prop-2-enoic acid monoargininyl salt |
| 09/04/2002 | EP1037646B1 Ginkgo biloba leaf extracts with a reduced 4'-o-methylpyridoxine and biflavone content |
| 09/04/2002 | EP0991647B1 Eprosartan monohydrate |
| 09/04/2002 | EP0929525B1 Heteroaryloxyethylamines as 5-ht1a receptor ligands |
| 09/04/2002 | EP0858459B1 Novel acid pyrazole derivatives, preparation method therefor, use thereof as drugs, novel use therefor, and pharmaceutical compositions containing such derivatives |
| 09/04/2002 | EP0832074B1 Amino acid derivatives of substituted quinoxaline 2,3-dione derivatives as glutamate receptor antagonists |
| 09/04/2002 | EP0830348B1 Cyclic amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists |
| 09/04/2002 | EP0809636B1 Substituted isoxazoles for the treatment of inflammation |
| 09/04/2002 | EP0801574A4 Modulation of integrin-mediated signal transduction |
| 09/04/2002 | EP0775143B1 3-substituted 3h-2,3-benzodiazepine derivatives, their preparation and use as medicaments |
| 09/04/2002 | EP0760664B1 Use of pteridine derivatives as no-synthase inhibitors |
| 09/04/2002 | EP0746551B1 Optically pure 4-aryl-2-hydroxytetronic acids |
| 09/04/2002 | EP0682526B1 PULMONARY ADMINISTRATION OF THE SOLUBLE COMPLEM RECEPTOR TYPE 1 sCR1 |
| 09/04/2002 | CN2508758Y Zhi ling shuan-suppository for treating hemorrhoid |
| 09/04/2002 | CN1367793A Neuromedin B and somatostatin receptor agonists |
| 09/04/2002 | CN1367792A Somatostatin agonists |
| 09/04/2002 | CN1367791A Novel angiogenesis inhibitor |
| 09/04/2002 | CN1367787A Water soluble SDZ-RAD esters |
| 09/04/2002 | CN1367778A Novel carboxylic acid derivatives with 5,6 substitutedpyrimidine ring, their production and utilization thereof as endothelin receptor antagonists |
| 09/04/2002 | CN1367775A Cubane derivatives as metabotropic glutamate receptor antagonists and process for their preparation |
| 09/04/2002 | CN1367696A Method of enhancing insulin action |